| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. | Director | Common Stock | 16.3K | $543K | $33.32 | Jun 11, 2025 | Direct |
| PTC THERAPEUTICS, INC. | Director | Common Stock | 8K | $531K | $66.40 | Nov 20, 2025 | Direct |
| PTC THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 8.8K | $238K | $27.05 | Jan 3, 2025 | Direct |
| Catalent, Inc. | Director | Common Stock | 0 | $0 | $59.70 | Dec 18, 2024 | Direct |
| Crinetics Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 10.4K | Jun 11, 2025 | Direct | ||
| ALBIREO PHARMA, INC. | Director | Stock Option (right to buy) | 0 | Mar 2, 2023 | Direct |